Registry

Module Specifications

Current Academic Year 2012 - 2013
Please note that this information is subject to change.

Module Title Functional Definition of Drug Targets
Module Code BE520
School School of Biotechnology
Online Module Resources

Module Co-ordinatorSemester 1: Ciaran Fagan
Semester 2: Ciaran Fagan
Autumn: Ciaran Fagan
NFQ level 8 Credit Rating 5
Pre-requisite None
Co-requisite None
Compatibles None
Incompatibles None
Description
This module aims to provide the following: - basic understanding of cellular “target” identification and structural elucidation approaches. - a basic understanding of rational design of drugs to interact with specific cellular target proteins. - an understanding of the importance of molecular 3D structure in the drug design processIt will allow students to study specific therapeutic interventions on a case study basis.It will show how naturally-occurring bioactive materials can be used: (i) to probe cellular processes; and (ii) as therapeutic interventions for abnormal activities. It will also show how protein engineering can yield “improved” therapeutics

Learning Outcomes
1. Explain protein strcutural biochemistry and understand "structure-function" analysis
2. Implement target structural elucidation and rationale drug design
3. Describe drug interactions with cellular targets
4. Discriminate physiological targets for specific therapeutic intervention
5. Apply protein engineering for elucidating structure-function relationships and for refining therapeutic effectiveness.



Workload Full-time hours per semester
Type Hours Description
Lecture20No Description
Independent learning105No Description
Total Workload: 125

All module information is indicative and subject to change. For further information,students are advised to refer to the University's Marks and Standards and Programme Specific Regulations at: http://www.dcu.ie/registry/examinations/index.shtml

Indicative Content and Learning Activities
module content.
Introduction to Pharmacology/BioPharma (including Protein & Nucleic acid drugs). Introduction to Protein Structural Biochemistry (structure-function analysis. Drug-Protein Interactions. Case Studies: Drug-Target Molecular Interactions (case studies for established vasotherapeutics etc.). Case studies: Protein Engineering of Enhanced Insulin & Erythropoietin (EPO) Therapeutics: Structure-Function Relationships.

Assessment Breakdown
Continuous Assessment0% Examination Weight100%
Course Work Breakdown
TypeDescription% of totalAssessment Date
Assignmentn/a25%n/a
In Class Testn/a75%n/a
Reassessment Requirement
Resit arrangements are explained by the following categories;
1 = A resit is available for all components of the module
2 = No resit is available for 100% continuous assessment module
3 = No resit is available for the continuous assessment component
This module is category 1
Indicative Reading List
  • Wingard et al: 0, Human Pharmacology - Molecular to Clinical,
  • Walsh: 0, Protein Biochemistry and Biotechnology,
  • Buxbaum: 0, Fundamentals of Protein Structure and function,
  • Madsen: 0, Textbook of Drug Design and Discovery,
Other Resources
None
Array
Programme or List of Programmes
AMPDPhD
AMPMMSc
AMPTPhD-track
BTPDPhD
BTPMMSc
BTPTPhD-track
CHPDPhD
CHPMMaster of Science
CHPTPhD-track
GTEGraduate Training Elements (Non Award)
NSPDPhD
NSPMMSc
NSPTPhD-track
PHPDPhD
PHPMMSc
PHPTPhD-track
SSPDPhD
SSPMMSc
SSPTPhD-track
Timetable this semester: Timetable for BE520
Archives: